95 related articles for article (PubMed ID: 22320866)
21. Lack of an association between Paraoxonase 1 gene polymorphisms (Q192R, L55M) and Alzheimer's disease: a meta-analysis.
Pi Y; Zhang L; Chang K; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
Neurosci Lett; 2012 Aug; 523(2):174-9. PubMed ID: 22776645
[TBL] [Abstract][Full Text] [Related]
22. Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies.
Wheeler JG; Keavney BD; Watkins H; Collins R; Danesh J
Lancet; 2004 Feb; 363(9410):689-95. PubMed ID: 15001326
[TBL] [Abstract][Full Text] [Related]
23. Significant association between paraoxonase 1 rs662 polymorphism and coronary heart disease : A meta-analysis in the Chinese population.
Deng Z; Xiang H; Gao W
Herz; 2020 Jun; 45(4):347-355. PubMed ID: 30128909
[TBL] [Abstract][Full Text] [Related]
24. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
[TBL] [Abstract][Full Text] [Related]
25. PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease.
Sharma R; Singh B; Mahajan M
Kaohsiung J Med Sci; 2007 May; 23(5):225-31. PubMed ID: 17525004
[TBL] [Abstract][Full Text] [Related]
26. Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.
Singh S; Venketesh S; Verma JS; Verma M; Lellamma CO; Goel RC
Indian J Med Res; 2007 Jun; 125(6):783-7. PubMed ID: 17704557
[TBL] [Abstract][Full Text] [Related]
27. Smoking is associated with reduced serum levels of the antioxidant enzyme, paraoxonase, in Type 2 diabetic patients.
Boemi M; Sirolla C; Testa R; Cenerelli S; Fumelli P; James RW
Diabet Med; 2004 May; 21(5):423-7. PubMed ID: 15089785
[TBL] [Abstract][Full Text] [Related]
28. [The antioxidant function of high density lipoproteins: a new paradigm in atherosclerosis].
Tomás M; Latorre G; Sentí M; Marrugat J
Rev Esp Cardiol; 2004 Jun; 57(6):557-69. PubMed ID: 15225502
[TBL] [Abstract][Full Text] [Related]
29. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
Gugliucci A
Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
[TBL] [Abstract][Full Text] [Related]
30. Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in Southwestern Taiwan.
Li WF; Sun CW; Cheng TJ; Chang KH; Chen CJ; Wang SL
Toxicol Appl Pharmacol; 2009 Apr; 236(2):246-53. PubMed ID: 19371607
[TBL] [Abstract][Full Text] [Related]
31. Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome.
Ferré N; Feliu A; García-Heredia A; Marsillach J; París N; Zaragoza-Jordana M; Mackness B; Mackness M; Escribano J; Closa-Monasterolo R; Joven J; Camps J
Clin Biochem; 2013 Dec; 46(18):1830-6. PubMed ID: 24028901
[TBL] [Abstract][Full Text] [Related]
32. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
Lacinski M; Skorupski W; Cieslinski A; Sokolowska J; Trzeciak WH; Jakubowski H
Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):885-93. PubMed ID: 15704252
[TBL] [Abstract][Full Text] [Related]
33. A study on serum advanced glycation end products and its association with oxidative stress and paraoxonase activity in type 2 diabetic patients with vascular complications.
Bansal S; Chawla D; Siddarth M; Banerjee BD; Madhu SV; Tripathi AK
Clin Biochem; 2013 Jan; 46(1-2):109-14. PubMed ID: 23103709
[TBL] [Abstract][Full Text] [Related]
34. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
[TBL] [Abstract][Full Text] [Related]
35. Paraoxonase 1 genetic polymorphisms and susceptibility to breast cancer: a meta-analysis.
Saadat M
Cancer Epidemiol; 2012 Apr; 36(2):e101-3. PubMed ID: 22133529
[TBL] [Abstract][Full Text] [Related]
36. Paraoxonase-1 (PON1) activity in patients with coronary artery diseases and in diabetic patients.
Amine K; Atouk A; Moussamih S; Saile R; Mikou A; Kettani A
Ann Biol Clin (Paris); 2011; 69(6):671-7. PubMed ID: 22123566
[TBL] [Abstract][Full Text] [Related]
37. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
[TBL] [Abstract][Full Text] [Related]
38. ABCA1 rs4149313 polymorphism and susceptibility to coronary heart disease: a meta-analysis.
Fan SL; Li X; Chen SJ; Qi GX
Ann Hum Genet; 2014 Jul; 78(4):264-76. PubMed ID: 24942079
[TBL] [Abstract][Full Text] [Related]
39. Paraoxonase 1 activity in patients with chronic obstructive pulmonary disease.
Rumora L; Rajković MG; Kopčinović LM; Pancirov D; Čepelak I; Grubišić TŽ
COPD; 2014 Sep; 11(5):539-45. PubMed ID: 24831724
[TBL] [Abstract][Full Text] [Related]
40. Decreased serum paraoxonase 1 (PON1) activity: an additional risk factor for atherosclerotic heart disease in patients with PCOS?
Dursun P; Demirtaş E; Bayrak A; Yarali H
Hum Reprod; 2006 Jan; 21(1):104-8. PubMed ID: 16155079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
